Følg
Matías Blaustein
Matías Blaustein
iB3-DFBMC-FCEyN-UBA / CONICET, Buenos Aires, Argentina
Verifisert e-postadresse på fbmc.fcen.uba.ar - Startside
Tittel
Sitert av
Sitert av
År
A slow RNA polymerase II affects alternative splicing in vivo
M de la Mata, CR Alonso, S Kadener, JP Fededa, M Blaustein, F Pelisch, ...
Molecular cell 12 (2), 525-532, 2003
8092003
DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation
MJ Muñoz, MSP Santangelo, MP Paronetto, M de la Mata, F Pelisch, ...
Cell 137 (4), 708-720, 2009
3272009
Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT
M Blaustein, F Pelisch, T Tanos, MJ Munoz, D Wengier, L Quadrana, ...
Nature structural & molecular biology 12 (12), 1037-1044, 2005
2802005
Akt/PKB: one kinase, many modifications
G Risso, M Blaustein, B Pozzi, P Mammi, A Srebrow
Biochemical Journal 468 (2), 203-214, 2015
1692015
Signals, pathways and splicing regulation
M Blaustein, F Pelisch, A Srebrow
The international journal of biochemistry & cell biology 39 (11), 2031-2048, 2007
1182007
Argonaute-1 binds transcriptional enhancers and controls constitutive and alternative splicing in human cells
M Alló, E Agirre, S Bessonov, P Bertucci, L Gómez Acuña, V Buggiano, ...
Proceedings of the National Academy of Sciences 111 (44), 15622-15629, 2014
972014
Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase
M Blaustein, F Pelisch, OA Coso, MJ Bissell, AR Kornblihtt, A Srebrow
Journal of Biological Chemistry 279 (20), 21029-21037, 2004
712004
Involvement of hnRNP A1 in the matrix metalloprotease‐3‐dependent regulation of Rac1 pre‐mRNA splicing
F Pelisch, D Khauv, G Risso, M Stallings‐Mann, M Blaustein, L Quadrana, ...
Journal of cellular biochemistry 113 (7), 2319-2329, 2012
662012
Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells
Scientific reports 10 (1), 21779, 2020
652020
Control of alternative pre-mRNA splicing by RNA Pol II elongation: faster is not always better
G Nogués, S Kadener, P Cramer, M De la Mata, JP Fededa, M Blaustein, ...
IUBMB life 55 (4-5), 235-241, 2003
602003
PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer
M Riggio, ML Polo, M Blaustein, A Colman-Lerner, I Lüthy, C Lanari, ...
Carcinogenesis 33 (3), 509-518, 2012
592012
Cross-talk between Signaling Pathways Regulates AlternativeSplicing: A NOVEL ROLE FORJNK
F Pelisch, M Blaustein, AR Kornblihtt, A Srebrow
Journal of Biological Chemistry 280 (27), 25461-25469, 2005
512005
AKT
M Blaustein
Encyclopedia of Signaling Molecules 2, 2018
45*2018
Yeast GPCR signaling reflects the fraction of occupied receptors, not the number
A Bush, G Vasen, A Constantinou, P Dunayevich, IL Patop, M Blaustein, ...
Molecular systems biology 12 (12), 898, 2016
382016
Modification of Akt by SUMO conjugation regulates alternative splicing and cell cycle
G Risso, F Pelisch, B Pozzi, P Mammi, M Blaustein, A Colman-Lerner, ...
Cell Cycle 12 (19), 0--1, 2013
362013
Modulation of the Akt pathway reveals a novel link with PERK/eIF2α, which is relevant during hypoxia
M Blaustein, D Pérez-Munizaga, MA Sánchez, C Urrutia, A Grande, ...
PLoS One 8 (7), e69668, 2013
322013
Tumor necrosis factor alpha induces LIF expression through ERK1/2 activation in mammary epithelial cells
CS Levy, V Slomiansky, A Gattelli, K Nahmod, F Pelisch, M Blaustein, ...
Journal of cellular biochemistry 110 (4), 857-865, 2010
312010
Regulation of fibronectin alternative splicing by a basement membrane-like extracellular matrix
A Srebrow, M Blaustein, AR Kornblihtt
FEBS letters 514 (2-3), 285-289, 2002
252002
SF2/ASF regulates proteomic diversity by affecting the balance between translation initiation mechanisms
M Blaustein, L Quadrana, G Risso, M Mata, F Pelisch, A Srebrow
Journal of cellular biochemistry 107 (4), 826-833, 2009
182009
Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda
FE Testoni, M García Carrillo, MA Gagnon, C Rikap, M Blaustein
PloS one 16 (4), e0249661, 2021
152021
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20